Monashee Investment Management LLC Takes Position in CRISPR Therapeutics AG $CRSP
Monashee Investment Management LLC has initiated a new position in CRISPR Therapeutics AG (NASDAQ:CRSP) during the first quarter, acquiring 50,000 shares valued at approximately $2.38 million, representing 1.3% of its portfolio. This move comes as CRISPR Therapeutics' stock has recently traded down 1.9% at …